The Amsterdam stock exchange AEX 434.43 – 0.26% – 1.13 Thursday delivers weather in a large part of the profits. Around four o’clock the Amsterdam Stock Exchange at 443.91 points, almost 2% higher than Wednesday. Earlier in the day, the AEX goods saw nearly 3% after it became known that the European Central Bank (ECB) stimulus package for the economy expands sharply. But President Mario Draghi of the ECB showed during a press conference hinted that further rate cuts in the future as far as he will not be needed. Then the European stock markets gave back a portion of their profits. Around four o’clock rates most European stock markets around 2% in the plus. In New York, the indicators are a few tenths in the plus. The Dow Jones index and the S & amp; P 500 both win 0.3%
The Midcap Midcap 658.84 – 0.69% – 4.55 gaining 0.5% while the ascx flat heads. The euro Euro / dollar 1.11 + 1.35% + 0, 01 weakened initially sharply on the news now heads to even higher against the dollar. The European currency is 0.4% higher at $ 1.1040. The interest rates on German government bonds with a maturity of 10 years is still slightly lower at 0.210%. Yields in the southern euro countries are going down faster, as the Portuguese interest rates fall by 18 basis points to 2.952%.
Crane further open put
President of the ECB Mario Draghi told a news conference that the Bank starting next month for € 20 billion more will buy up bonds. Photo: Reuters
From next month, the ECB for € 20 bn more buying bonds. This brings the monthly amount to € 80 billion. The deposit rate will be lowered to 0.4% by 10 basis points. Banks pay since June 2014 for parking money at the ECB. This is the third reduction since. With this measure, the ECB hopes that banks will lend money instead of parking at the ECB.
The AEX is the French cable company Altice Altice 14.75 + 5.40% 0.76 + frontrunner, followed by Boskalis Royal Boskalis Westminster 31.70 + 5.05% +1.53 and ING ING Groep NV 11.36 + 1.75% 0.20 + . Wednesday Boskalis was a huge blow. Disappointing figures and weak prospects did the course yesterday with almost € 6 decline, a loss of 16%.
The oil price drops Thursday, but Brent still costs a little over $ 40.
Shell Oil Fund Royal Dutch Shell a Shs 21.23 – 3.02% – 0.66 received a buy recommendation Kepler Cheuvreux, with a target price of € 25. Shell is one of the few decliners in the index. On Thursday it became clear that the company last year for $ 9.3 billion has been impaired assets. That is over 36% more than in 2014 when nearly $ 6.85 billion was written off. That is to make the annual report for 2015 that Shell has filed today. Possibly the share price also suffered from falling oil prices. Also insurer NN Group to hand light.
New Composition
Woensdagavond came exchange operator Euronext with the new composition of the Amsterdam indices. It appeared that the insurer Delta Lloyd and OCI to give up their places in the AEX. ABN Amro and SBM Offshore promoted to the AEX. BinckBank and Fagron degrade the Midcap, supplemented with Intertrust and property fund WDP.
Midkapper Aperam Aperam 30.87 – 2.53% – 0.80 Thursday quoted ex-dividend. Van Lanschot Van Lanschot 19.63 – 2.36% – 0.48 gave a price target reduction of ING, from € 27.50 to € 23. Analyst shortly Albert Ploegh sees difficult market conditions, but will share the long term is still worth buying. Van Lanschot promoted later this month for the index.
Refresco
Refresco Gerber Refresco Gerber BV 14.69 – 0.74 % – 0.11 , part of the small-cap index, came up with figures. The bottler and juices producer speaks of a strong year in which net income rose from € 38.7 million to € 41.8 million. This profit was still impacted by non-recurring costs associated with the IPO. Sales fell by 1% to € 2.02 billion, according to the company due to lower purchase prices were passed on to customers. Measured in liters increased sales volume by 2.1% in 2015. CEO Hans Roelofs said he expected growth in sales volume in 2016 will be at the same pace as last year, while the gross margin per liter fractionally will be lower
Pharming Pharming Group NV 0.24 – 21.64% – 0.07 be poorly received. Leiden biotech company has managed to halve its loss compared to 2014. 2015 ended with a loss of € 10 million, compared with € 22 million a year earlier. Revenue from product sales increased from € 3 million to € 8.6 million, mainly due to good business in the US CEO Sijmen de Vries expects “an even more positive in 2016.
Exhibition Dwarf RoodMicrotec RoodMicrotec 0 23 – 4.94% – 0.01 expressed very optimistic about the sales trend for the coming years . Which will ‘substantial’ growth, the company said. This year sales growth at the top of the previously guided range of 7% to 12% off. About 2015 it reported a turnover of € 10.3 million, as it turned out for scholarship. This resulted in a negative gross operating profit (EBITDA) of € 0.3 million.
No comments:
Post a Comment